THE NITRATE ESTER ITF-296 RELAXES ISOLATED CANINE ARTERIES AND VEINS

Citation
B. Desta et al., THE NITRATE ESTER ITF-296 RELAXES ISOLATED CANINE ARTERIES AND VEINS, Journal of cardiovascular pharmacology, 26, 1995, pp. 53-58
Citations number
23
Categorie Soggetti
Cardiac & Cardiovascular System","Respiratory System","Pharmacology & Pharmacy
ISSN journal
01602446
Volume
26
Year of publication
1995
Supplement
4
Pages
53 - 58
Database
ISI
SICI code
0160-2446(1995)26:<53:TNEIRI>2.0.ZU;2-U
Abstract
Experiments were designed to compare the relaxant activity of the new nitrate ester ITF 296 in isolated arteries and veins of the dog and to determine the extent of modulation by the endothelium of the response to the compound. Rings (with and without endothelium) of coronary, ba silar, mesenteric, and femoral arteries and of mesenteric, femoral, an d saphenous veins were suspended in organ chambers for measurement of changes in isometric tension. In all blood vessels without endothelium , ITF 296 caused concentration-dependent relaxation. The order of pote ncy (from measurements of ED(50)) was: basilar artery greater than or equal to coronary artery > femoral artery > mesenteric vein > femoral vein > saphenous vein > mesenteric artery. The maximal relaxation to I TF 296 was greater in the arteries (with the exception of the mesenter ic) than in veins. In all blood vessels except for the basilar artery, nitroglycerin caused larger relaxations than ITF 296: The ED(50) for nitroglycerin was comparable in all blood vessels studied except for t he mesenteric artery, where it was less. ITF 296 did not cause hyperpo larization of vascular smooth muscle in coronary arteries either with or without endothelium. The presence of endothelial cells blunted the relaxation to ITF 296 in basilar and coronary arteries, but not in the other blood vessels studied. These results demonstrate that ITF 296 h as a direct inhibitory effect on vascular smooth muscle, which is most pronounced in coronary and cerebral arteries. These findings are in l ine with the vascular selectivity profile reported for the compound in vivo.